GP-Act III Acquisition (GPATW) Cash & Equivalents (2023 - 2026)

GP-Act III Acquisition (GPATW) has reported Cash & Equivalents for 4 consecutive years, with $10586.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 95.7% year-over-year to $10586.0; the trailing twelve-month figure through Jun 2026 stood at $10586.0 (down 95.7% YoY), and the FY2025 full-year result was $112660.0, down 76.7% from the prior year.
• Cash & Equivalents declined to $10586.0 in Q2 2026 per GPATW's latest filing, from $112660.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $571765.0 in Q2 2024 and bottomed at $1208.0 in Q4 2023.
• Historically, Cash & Equivalents has averaged $247336.9 across 4 years, with a median of $246314.0 in 2025.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents jumped 39930.79% in 2024, then tumbled 95.7% in 2026.
• Over 4 years, Cash & Equivalents stood at $1208.0 in 2023, then surged by 39930.79% to $483572.0 in 2024, then plunged by 76.7% to $112660.0 in 2025, then sank by 90.6% to $10586.0 in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $10586.0, $112660.0, and $250000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.